Related Experiment Video
Updated: Sep 14, 2025
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Subconjunctival dexamethasone implant (Ozurdex) for peripheral ulcerative keratitis
Hashem H Ghoraba1, Chris Or1, Aneesha Ahluwalia1
1Byers Eye Institute, Stanford University, USA.
Purpose:
To report a case of peripheral ulcerative keratitis (PUK) successfully treated with subconjunctival dexamethasone implant (Ozurdex®) injection.
Observations:
An 82-year-old female presented with PUK in the right eye. Systemic immunosuppressive treatment with steroids and methotrexate resulted in complete healing. The patient developed adverse events that led to discontinuation of systemic therapy. Nine months after presentation, the PUK recurred, and the patient declined to restart systemic therapy. Subconjunctival dexamethasone implant injection resulted in complete resolution. The patient received three injections over a period of 10 months. No scleral melt or ocular hypertension was noted 11 months after the first injection.
Conclusions And Importance:
Subconjunctival dexamethasone implant injection can be a well-tolerated treatment option for peripheral ulcerative keratitis.
More Related Videos
06:19Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
Published on: May 31, 2024
07:29Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
Published on: November 12, 2015
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment